| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
|
|
| | | FI | | | Voriconazol Sandoz 200 mg | Durchstechflasche(n) | 132.94 | 169.00 | 10% | 338.00 | Lyophilisat: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | | FI | PI | | Oxycodon Streuli 5mg | 30 Tablette(n) | 8.20 | 17.60 | 10% | 8.80 | Retard-Tabletten: Oxycodoni Hydrochloridum 5 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 5mg | 60 Tablette(n) | 14.45 | 28.90 | 10% | 7.22 | Retard-Tabletten: Oxycodoni Hydrochloridum 5 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 10mg | 30 Tablette(n) | 11.18 | 25.15 | 10% | 6.29 | Retard-Tabletten: Oxycodoni Hydrochloridum 10 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 10mg | 60 Tablette(n) | 19.67 | 39.00 | 10% | 4.88 | Retard-Tabletten: Oxycodoni Hydrochloridum 10 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 20mg | 30 Tablette(n) | 18.87 | 38.05 | 10% | 4.76 | Retard-Tabletten: Oxycodoni Hydrochloridum 20 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 20mg | 60 Tablette(n) | 36.07 | 57.80 | 10% | 3.61 | Retard-Tabletten: Oxycodoni Hydrochloridum 20 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 40mg | 30 Tablette(n) | 39.14 | 61.35 | 10% | 3.83 | Retard-Tabletten: Oxycodoni Hydrochloridum 40 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 40mg | 60 Tablette(n) | 75.59 | 103.20 | 10% | 3.22 | Retard-Tabletten: Oxycodoni Hydrochloridum 40 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 80mg | 30 Tablette(n) | 68.65 | 95.20 | 10% | 3.17 | Retard-Tabletten: Oxycodoni Hydrochloridum 80 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Oxycodon Streuli 80mg | 60 Tablette(n) | 137.21 | 173.90 | 10% | 2.90 | Retard-Tabletten: Oxycodoni Hydrochloridum 80 mg | Streuli Pharma AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 20 mg | 14 Tablette(n) | 5.60 | 14.65 | 10% | 1.57 | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 20 mg | 30 Tablette(n) | 11.00 | 24.95 | 10% | 1.25 | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 20 mg | 60 Tablette(n) | 18.90 | 38.10 | 10% | 0.95 | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 20 mg | 100 Tablette(n) | 30.30 | 51.20 | 10% | 0.77 | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 20 mg | 100 Tablette(n) | 30.30 | 51.20 | 10% | 0.77 | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 40 mg | 14 Tablette(n) | 6.20 | 15.30 | 10% | 0.82 | magensaftresistente Filmtabletten: Esomeprazolum 40 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 40 mg | 30 Tablette(n) | 11.20 | 25.15 | 10% | 0.63 | magensaftresistente Filmtabletten: Esomeprazolum 40 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 40 mg | 60 Tablette(n) | 20.90 | 40.40 | 10% | 0.50 | magensaftresistente Filmtabletten: Esomeprazolum 40 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 40 mg | 100 Tablette(n) | 36.90 | 58.75 | 10% | 0.44 | magensaftresistente Filmtabletten: Esomeprazolum 40 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Esomeprazol Spirig HC 40 mg | 100 Tablette(n) | 36.90 | 58.75 | 10% | 0.44 | magensaftresistente Filmtabletten: Esomeprazolum 40 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | ColiFin PARI 2 Mio. U.I. | 56 | 2464.56 | 2764.50 | 10% | | poudre pour solution pour inhalation par nébuliseur: Colistimethatum Natricum 2 Mio UI | Vifor SA | A / SL / SG | FB | | G | |
| | | FI | PI | PS | Plegridy Pen, 63 mcg/0.5 ml | Kombipackung(en) | 1034.37 | 1195.95 | 10% | | Peginterferonum Beta-1a 63µg / 0.5ml | Biogen Switzerland AG | B / SL | FB | | G | |
| | | FI | PI | PS | Plegridy Pen, 125 mcg/0.5 ml | 2 Stück | 1077.28 | 1243.00 | 10% | | Peginterferonum Beta-1a 125µg / 0.5ml | Biogen Switzerland AG | B / SL | FB | | G | |
| | | FI | PI | PS | Plegridy, 63 mcg/0.5 ml | Kombipackung(en) | 1034.37 | 1195.95 | 10% | | Peginterferonum Beta-1a 63µg / 0.5ml | Biogen Switzerland AG | B / SL | FB | | G | |
| | | FI | PI | PS | Plegridy, 125 mcg/0.5 ml | 2 Fertigspritze(n) | 1077.28 | 1243.00 | 10% | | Peginterferonum Beta-1a 125µg / 0.5ml | Biogen Switzerland AG | B / SL | FB | | G | |
| | | FI | PI | | Abasaglar cartouche 100
U/ml | 5 x 3 ml | 44.05 | 66.95 | 10% | 66.95 | Injektionslösung: Insulinum Glarginum 3.64 mg/ml | Eli Lilly (Suisse) SA | B / SL | FB | | G | |
| | | FI | PI | | Abasaglar KwikPen 100
U/ml | 5 x 3 ml | 45.30 | 68.40 | 10% | 68.40 | Injektionslösung: Insulinum Glarginum 3.64 mg/ml | Eli Lilly (Suisse) SA | B / SL | FB | | G | |
| L | | FI | PI | PS | Moventig 12.5 mg | 30 Tablette(n) | 79.95 | 108.20 | 10% | 7.21 | Filmtabletten: Naloxegolum 12.5 mg | Kyowa Kirin Sàrl | B / SL | FB | | G | |
| L | | FI | PI | PS | Moventig 25 mg | 30 Tablette(n) | 79.95 | 108.20 | 10% | 3.61 | Filmtabletten: Naloxegolum 25 mg | Kyowa Kirin Sàrl | B / SL | FB | | G | |
| L | | FI | PI | PS | Moventig 25 mg | 90 Tablette(n) | 238.07 | 289.70 | 10% | 3.22 | Filmtabletten: Naloxegolum 25 mg | Kyowa Kirin Sàrl | B / SL | FB | | G | |
| L | | FI | PI | | Otezla 30mg | 56 Tablette(n) | 790.60 | 924.00 | 10% | 33.00 | Filmtabletten: Apremilastum 30 mg | Celgene GmbH | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 5 mg / 500 mg | 28 Tablette(n) | 25.85 | 46.10 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 5 mg / 500 mg | 98 Tablette(n) | 90.28 | 120.05 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 10 mg / 500 mg | 28 Tablette(n) | 51.69 | 75.75 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 10 mg / 500 mg | 98 Tablette(n) | 180.55 | 223.65 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 5 mg / 1000 mg | 28 Tablette(n) | 25.85 | 46.10 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 5 mg / 1000 mg | 98 Tablette(n) | 90.28 | 120.05 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 10 mg / 1000 mg | 28 Tablette(n) | 51.69 | 75.75 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | PS | Xigduo XR 10 mg / 1000 mg | 98 Tablette(n) | 180.55 | 223.65 | 10% | | Filmtabletten: 2 Wirkstoffe | AstraZeneca AG | B / SL | FB | | G | |
| L | | FI | PI | | Strattera 4mg/ml | Flasche(n) à 100 ml | 45.87 | 69.05 | 10% | 13.81 | Lösung (oral): Atomoxetinum 4 mg/ml | Eli Lilly (Suisse) SA | A / SL | FB | | G | |
| L | | FI | PI | | Otezla 10 mg, 20 mg | 19 Tablette(n) | 375.09 | 447.00 | 10% | 19.43 | mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg | Celgene GmbH | B / SL | FB | | G | |
| | | FI | PI | | Prezista 100 mg/ml | Flasche(n) | PA | PA | k.A. | | | Janssen-Cilag AG | A | FB | | G | |
| | | FI | | | Ampres 10 mg/ml | 10 1 Ampulle(n) à 5 ml | PA | PA | k.A. | | Injektionslösung: Chloroprocaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | FI | | | Ampres 20 mg/ml | Durchstechflasche(n) à 20 ml | PA | PA | k.A. | | Injektionslösung: Chloroprocaini Hydrochloridum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | FI | | | Ampres 20 mg/ml | 5 1 Ampulle(n) à 20 ml | PA | PA | k.A. | | Injektionslösung: Chloroprocaini Hydrochloridum 20 mg/ml | Sintetica SA | B | FB | | G | |
| | | FI | | | Ampres 30 mg/ml | Durchstechflasche(n) à 20 ml | PA | PA | k.A. | | Injektionslösung: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | FI | | | Ampres 30 mg/ml | 5 1 Ampulle(n) à 20 ml | PA | PA | k.A. | | Injektionslösung: Chloroprocaini Hydrochloridum 30 mg/ml | Sintetica SA | B | FB | | G | |
| | | FI | | | Oxynorm Inject 10mg/1ml | 5 1 Ampulle(n) à 1 ml | PA | PA | k.A. | | Injektionslösung: Oxycodoni Hydrochloridum 10 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | | FI | | | Oxynorm Inject 200mg/20ml | 4 1 Ampulle(n) à 20 ml | PA | PA | k.A. | | Injektionslösung: Oxycodoni Hydrochloridum 200mg / 20ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | | FI | | | Oxynorm Inject 50mg/1ml | 5 1 Ampulle(n) à 1 ml | PA | PA | k.A. | | Injektionslösung: Oxycodoni Hydrochloridum 50 mg/ml | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | | FI | PI | | Dafalgan Odis 250 mg | 16 Sachet(s) | PA | PA | k.A. | | Granulat: Paracetamolum 250 mg | Bristol-Myers Squibb SA | D | FB | | G | |
| | | FI | PI | | Algifor Liquid caps 400 | 10 Kapsel(n) | PA | PA | k.A. | | Capsule de gélatine molle: Ibuprofenum 400 mg | Verfora SA | D | FB | | G | |
| | | | PI | H | Viburcol | 15 x 1 ml | PA | PA | k.A. | | Flüssigkeit zum Einnehmen: 5 Wirkstoffe | ebi-pharm ag | D | FB | | G | |
| | | FI | PI | | Dafalgan Odis 500 mg | 16 Sachet(s) | PA | PA | k.A. | | Granulat (Erdbeer/Vanille): Paracetamolum 500 mg | Bristol-Myers Squibb SA | D | FB | | G | |
| | | FI | PI | Ph | Aplona | 20 Sachet(s) | PA | PA | k.A. | | Pulver zur Herstellung einer Suspension zum Einnehmen: Mali Fructus Siccati Pulvis 4.9 g | athenstaedt AG | D | FB | | G | |
| | | FI | PI | PS | Plegridy Pen, 94 mcg/0.5 ml | Kombipackung(en) | PA | PA | k.A. | | Peginterferonum Beta-1a 94µg / 0.5ml | Biogen Switzerland AG | B | FB | | G | |
| | | FI | PI | PS | Plegridy, 94 mcg/0.5 ml | Kombipackung(en) | PA | PA | k.A. | | Peginterferonum Beta-1a 94µg / 0.5ml | Biogen Switzerland AG | B | FB | | G | |
| | | FI | PI | | Abasaglar KwikPen 100
U/ml | 5 x 3 ml | 45.30 | 68.40 | k.A. | 68.40 | Injektionslösung: Insulinum Glarginum 3.64 mg/ml | Eli Lilly (Suisse) SA | B | FB | | G | |
| | | FI | PI | | Dafalgan Odis 250 mg | 40 Sachet(s) | PA | PA | k.A. | | Granulat: Paracetamolum 250 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | PI | | Dafalgan Odis 1000 mg | 16 Sachet(s) | PA | PA | k.A. | | Granulat: Paracetamolum 1000 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | PI | | Dafalgan Odis 1000 mg | 40 Sachet(s) | PA | PA | k.A. | | Granulat: Paracetamolum 1000 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | PI | | Dafalgan Odis 1000 mg | 100 Sachet(s) | PA | PA | k.A. | | Granulat: Paracetamolum 1000 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | | | Voriconazol Sandoz 200 mg | 5 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | FI | | | Voriconazol Sandoz 200 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat: Voriconazolum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | FI | PI | | Strattera 4mg/ml | 3 1 Flasche(n) à 100 ml | PA | PA | k.A. | | Lösung (oral): Atomoxetinum 4 mg/ml | Eli Lilly (Suisse) SA | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 200 mg | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 200 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 1 g | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 1 g | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 2 g | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | | | Gemcitabine Pharmintraco 2 g | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G | |
| | | FI | PI | | Dafalgan Odis 500 mg | 16 Sachet(s) | PA | PA | k.A. | | Granulat (Cappuccino): Paracetamolum 500 mg | Bristol-Myers Squibb SA | D | FB | | G | |
| | | FI | PI | | Dafalgan Odis 500 mg | 40 Sachet(s) | PA | PA | k.A. | | Granulat (Cappuccino): Paracetamolum 500 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | PI | | Dafalgan Odis 500 mg | 40 Sachet(s) | PA | PA | k.A. | | Granulat (Erdbeer/Vanille): Paracetamolum 500 mg | Bristol-Myers Squibb SA | B | FB | | G | |
| | | FI | PI | Ph | Aplona | 50 Sachet(s) | PA | PA | k.A. | | Pulver zur Herstellung einer Suspension zum Einnehmen: Mali Fructus Siccati Pulvis 4.9 g | athenstaedt AG | D | FB | | G | |
| | | FI | PI | | Nexium Control 20 mg | 7 Tablette(n) | PA | PA | k.A. | | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Pfizer AG | C | FB | | G | |
| | | FI | PI | | Nexium Control 20 mg | 14 Tablette(n) | PA | PA | k.A. | | magensaftresistente Filmtabletten: Esomeprazolum 20 mg | Pfizer AG | C | FB | | G | |
